Gyre Therapeutics GYRE
NASDAQ GYRE
$4.30 +0.07 (+1.65%)
As of: Nov 11, 2026 · 11:17 AM EST

Gyre Therapeutics (GYRE) Preferred Shares (2023 - 2026)

Updated

Gyre Therapeutics' Preferred Shares came in at $33.31 million for Q3 2023.

Analysis

Gyre Therapeutics (GYRE) Preferred Shares (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn 21.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.55 Mn
Sep 30, 2023 33.31 Mn
API Access

Gyre Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=GYRE&period=max&api_key=YOUR_API_KEY